U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2021
470
Name Type Language
LY-3832479
Preferred Name English
ETESEVIMAB
USAN   INN  
Official Name English
ANTI-SARS-COV-2 ANTIBODY JS016
Common Name English
CB6
Code English
JS016
Code English
NP-005
Code English
LY COV016
Code English
LY3832479
Code English
IMMUNOGLOBULIN G1*03-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN (PEPLOMER PROTEIN, E2))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-449) (HOMO SAPIENS VH (IGHV3-66*01 (97%) (IGHD)-IGHJ4*01 (93%)) (8.7.13) (1-119)-
Common Name English
CB-6
Code English
Etesevimab [WHO-DD]
Common Name English
JS-016
Code English
etesevimab [INN]
Common Name English
ETESEVIMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL JS016 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS016 .KAPPA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL LY3832479 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3832479 .KAPPA.-CHAIN, DIMER
Common Name English
NP005
Code English
LY-COV016
Code English
Code System Code Type Description
CAS
2423948-94-9
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
INN
11873
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
FDA UNII
N7Q9NLF11I
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
RXCUI
2477854
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
SMS_ID
300000026913
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
NCI_THESAURUS
C173977
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
DAILYMED
N7Q9NLF11I
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
USAN
JK-03
Created by admin on Sat Dec 16 16:08:06 GMT 2023 , Edited by admin on Sat Dec 16 16:08:06 GMT 2023
PRIMARY
ACTIVE MOIETY
ETESEVIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966